NHLBI Small Business Program
Important Change in Standard Due Dates for All HHS SBIR/STTR Grant Applications.HHS is changing its Standard Due Dates for SBIR/STTR grant applications to make funding recommendations and awards sooner. The next SBIR/STTR Omnibus Solicitation Deadline is September 5, 2015. There will not be an August 5, 2015 due date. Read more at NOT-OD-15-038and on the NIH SBIR website.
Upcoming Deadline for SBIR Phase IIB Awards (Bridge and Small Market). The next receipt date for the NHLBI Phase IIB programs is rapidly approaching. Applications are due June 19, 2015. Learn more about the Small Market Awards for technologies focused on rare diseases or pediatric indications and the Bridge Awards for other technologies requiring FDA approval.
New Videos! Tips on Your Commercialization Plan and Biologics Drug Development from pre-IND to Approval. Learn from NHLBI experts in our Small Biz Hangout series covering basics on Navigating the FDA Website and “First Contact” with FDA to more in-depth overviews on regulatory paths for Medical Devices and Biologics Regulation and including practical advice for your small business on “Writing Your Phase II Commercialization Plan” and “Finding the Right Regulatory Consultant.”
Learn more about the NHLBI Regional Innovation Conferences. NHLBI is committed to connecting small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries in various regions of the country. Read about past conferences here.
Welcome Aboard! New Staff Members join OTAC’s Small Business Team. Business Development Specialist Dr. Gary Robinson and Intellectual Property Advisor Dr. Gautam Prakash have recently brought their knowledge and expertise to the NHLBI’s Small Business Program, joining Regulatory Affairs Specialist Dr. Chris Sasiela. Our team of experts is available to provide advice to NHLBI awardees about developing a successful business model, navigating the FDA, and securing intellectual property. Contact Us to schedule a call.
NHLBI Companies Complete the Innovation Corps (I-Corps) at NIH. Three NHLBI SBIR/STTR Phase I awardees participated in the NIH I-Corps Team Training Pilot Program to support entrepreneurial education in overcoming key obstacles along the path to commercialization: Affinity Therapeutics, ReQuisite Biomedical, and Rosellini Scientific. Learn more at http://sbir.cancer.gov/icorps
Archives of What's New
Last Updated April 2015